Folgen
Ann Daly
Ann Daly
Professor of Pharmacogenetics, Newcastle University
Bestätigte E-Mail-Adresse bei ncl.ac.uk - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl, J Zhang, Y Lin, J Lamba, M Assem, J Schuetz, PB Watkins, ...
Nature genetics 27 (4), 383-391, 2001
27062001
Estimation of the warfarin dose with clinical and pharmacogenetic data
International Warfarin Pharmacogenetics Consortium
New England Journal of Medicine 360 (8), 753-764, 2009
18292009
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
GP Aithal, CP Day, PJL Kesteven, AK Daly
The Lancet 353 (9154), 717-719, 1999
16971999
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen
EA Sconce, TI Khan, HA Wynne, P Avery, L Monkhouse, BP King, P Wood, ...
Blood 106 (7), 2329-2333, 2005
12442005
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
AK Daly, PT Donaldson, P Bhatnagar, Y Shen, I Pe'er, A Floratos, MJ Daly, ...
Nature genetics 41 (7), 816-819, 2009
11722009
Case definition and phenotype standardization in drug‐induced liver injury
GP Aithal, PB Watkins, RJ Andrade, D Larrey, M Molokhia, H Takikawa, ...
Clinical Pharmacology & Therapeutics 89 (6), 806-815, 2011
11542011
Metabolic gene polymorphism frequencies in control populations
S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ...
Cancer Epidemiology Biomarkers & Prevention 10 (12), 1239-1248, 2001
11322001
A randomized trial of genotype-guided dosing of warfarin
M Pirmohamed, G Burnside, N Eriksson, AL Jorgensen, CH Toh, ...
New England Journal of Medicine 369 (24), 2294-2303, 2013
9652013
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ...
Nature 592 (7854), 450-456, 2021
8142021
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
6982010
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
YL Liu, HL Reeves, AD Burt, D Tiniakos, S McPherson, JBS Leathart, ...
Nature communications 5 (1), 4309, 2014
6882014
Nomenclature for human CYP2D6 alleles
AK Daly, J Brockmoller, F Broly, M Eichelbaum, WE Evans, FJ Gonzalez, ...
Pharmacogenetics and Genomics 6 (3), 193-201, 1996
6051996
Carriage of the PNPLA3 rs738409 C> G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
YL Liu, GL Patman, JBS Leathart, AC Piguet, AD Burt, JF Dufour, CP Day, ...
Journal of hepatology 61 (1), 75-81, 2014
5712014
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles
MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ...
Gastroenterology 141 (1), 338-347, 2011
5032011
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi, JT Backman, LI Kajosaari, JB Leathart, M Neuvonen, AK Daly, ...
Clinical Pharmacology & Therapeutics 77 (6), 468-478, 2005
4342005
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations
JK Lamba, YS Lin, K Thummel, A Daly, PB Watkins, S Strom, J Zhang, ...
Pharmacogenetics and Genomics 12 (2), 121-132, 2002
3992002
Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes
AK Daly, GP Aithal, JBS Leathart, RA Swainsbury, TS Dang, CP Day
Gastroenterology 132 (1), 272-281, 2007
3942007
Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis
J Grove, AK Daly, MF Bassendine, CP Day
Hepatology 26 (1), 143-146, 1997
3921997
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants
J Zhang, P Kuehl, ED Green, JW Touchman, PB Watkins, A Daly, SD Hall, ...
Pharmacogenetics and genomics 11 (7), 555-572, 2001
3822001
Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients12
E Thervet, D Anglicheau, B King, MH Schlageter, B Cassinat, P Beaune, ...
Transplantation 76 (8), 1233-1235, 2003
3722003
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20